SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2017

SHAREHOLDERS' EQUITY:

Stock Option Activity

A summary of the Company's option activity and related information with respect to options granted to employees and directors for the year ended December 31, 2017 is as follows:

	Number of options			Weighted-average exercise price		Weighted- average remaining contractual term (in years)		Aggregate intrinsic value
Outstanding at the beginning of the year		671,714		$	2.85		4.13	$	1,534
Granted		268,043		$	4.04
Exercised		(12,635	)	$	3.20
Forfeited		(24,753	)	$	4.53
Outstanding at end of year		902,369		$	3.12		4.21	$	1,267
Exercisable options at end of year		464,491		$	2.42		1.96	$	971

Schedule of Outstanding Options to Consultants

The Company's outstanding options to consultants as of December 31, 2017, were as follows:

Grant date	Options for Ordinary shares		Exercise price per share		Options exercisable		Exercisable through
October, 2015		54,075	$	4.52		30,418	October, 2022
		54,075				30,418

Schedule of Stock-Based Compensation Expense

The following table presents the stock-based compensation included in the line items below in the Company's consolidated statements of operations:

	Year ended December 31,
	2017		2016		2015
Cost of revenues	$	38	$	26	$	19
Research and development		10		16		19
Sales and marketing		62		82		45
General and administrative		100		445		61
Total	$	210	$	569	$	144